CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd.

17-1120

Overview

Case Number 17-1120
Filing Date 2016-10-28
Status Litigation filed
Court Court of Appeals for the Federal Circuit (cafc)
Nature of Suit 830 Patent Infringement (Fed. Question)
Cause of Action 35:271 Patent Infringement

Parties

Defendant

Celltrion Healthcare Co., Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Janssen Biotech, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

Court of Appeals for the Federal Circuit (cafc)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

No Co-Pending Disputes Detected in Current Index

There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.

Patents Involved

No asserted patent numbers detected in initial docket filings yet.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
RESPONSE of Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. to the motion to extend time to file appellant/petitioner principal brief...
Entry #29 • 2016-12-06 Document →
Procedural / Extension Motion Pending / Under Review
Letter from Appellees Celltrion Healthcare Co., Ltd., Celltrion, Inc. and Hospira Inc. Opposition to Janssen's Motion for Extension of Time (Dkt. 24). Service: ...
Entry #25 • 2016-12-05 Document →

Docket Entries

(45 total)

Appeal docketed. Received: 10/25/2016. [378336]Entry of Appearance due 11/14/2016. Certificate of Interest is due on 11/14/2016. Docketing Statement due 11/14/2016. Appellant's brief is due 12/27/2016.

Entry #1 • 2016-10-28
1

Entry of appearance for Gregory L. Diskant as principal counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382210]

Entry #2 • 2016-11-14
1

Entry of appearance for Eugene M. Gelernter as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382211]

Entry #3 • 2016-11-14
1

Entry of appearance for Aron Fischer as of counsel for Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382213]

Entry #5 • 2016-11-14
1

Docketing Statement for the Appellants Janssen Biotech, Inc. and New York University. Service: 11/11/2016 by US mail, email. [382214]

Entry #6 • 2016-11-14
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc